JP2021518748A5 - - Google Patents
Info
- Publication number
- JP2021518748A5 JP2021518748A5 JP2020544204A JP2020544204A JP2021518748A5 JP 2021518748 A5 JP2021518748 A5 JP 2021518748A5 JP 2020544204 A JP2020544204 A JP 2020544204A JP 2020544204 A JP2020544204 A JP 2020544204A JP 2021518748 A5 JP2021518748 A5 JP 2021518748A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antibody
- substantially similar
- heavy chain
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862634643P | 2018-02-23 | 2018-02-23 | |
| US62/634,643 | 2018-02-23 | ||
| PCT/US2019/019319 WO2019165326A1 (en) | 2018-02-23 | 2019-02-23 | Calcitonin gene-related peptide (cgrp) antagonist antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518748A JP2021518748A (ja) | 2021-08-05 |
| JP2021518748A5 true JP2021518748A5 (https=) | 2022-02-25 |
| JPWO2019165326A5 JPWO2019165326A5 (https=) | 2022-02-25 |
Family
ID=67688456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544204A Pending JP2021518748A (ja) | 2018-02-23 | 2019-02-23 | カルシトニン遺伝子関連ペプチド（ｃｇｒｐ）アンタゴニスト抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11629184B2 (https=) |
| EP (1) | EP3755327A4 (https=) |
| JP (1) | JP2021518748A (https=) |
| CN (1) | CN112040949A (https=) |
| WO (1) | WO2019165326A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117916259A (zh) * | 2021-09-30 | 2024-04-19 | 江苏恒瑞医药股份有限公司 | 特异性结合cgrp和pacap的抗原结合分子及其医药用途 |
| WO2024032750A1 (zh) * | 2022-08-11 | 2024-02-15 | 上海君实生物医药科技股份有限公司 | 抗cgrp抗体及用途 |
| CN118271438B (zh) * | 2024-05-27 | 2024-08-30 | 上海宏成药业有限公司 | 抗cgrp抗体或其抗原结合片段及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY153249A (en) * | 2005-11-14 | 2015-01-29 | Rinat Neuroscience Corp | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| WO2007076336A1 (en) * | 2005-12-22 | 2007-07-05 | Eli Lilly And Company | Treatment of migraine with anti-cgrp antibodies |
| US20080171038A1 (en) | 2006-11-08 | 2008-07-17 | Kalobios Pharmaceuticals, Inc. | Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| JPWO2009051220A1 (ja) | 2007-10-19 | 2011-03-03 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| TWI516501B (zh) * | 2008-09-12 | 2016-01-11 | 禮納特神經系統科學公司 | Ｐｃｓｋ９拮抗劑類 |
| JP5992831B2 (ja) | 2009-12-24 | 2016-09-14 | バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド | 非機能性オリゴマーｐ２ｘ７受容体に対する抗体 |
| CN103037900B (zh) * | 2010-02-24 | 2016-04-06 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| TWI685505B (zh) * | 2011-05-20 | 2020-02-21 | 美商艾爾德生物控股有限責任公司 | 抗降血鈣素基因相關胜肽（ａｎｔｉ-ｃｇｒｐ）組成物及其用途 |
| WO2014059442A2 (en) * | 2012-10-12 | 2014-04-17 | Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Antibody based reagents that specifically recognize toxic oligomeric forms of tau |
| US9629801B2 (en) * | 2014-01-10 | 2017-04-25 | Wisconsin Alumni Research Foundation | Blood-brain barrier targeting antibodies |
| WO2015199618A1 (en) | 2014-06-24 | 2015-12-30 | National University Of Singapore | Epstein-barr virus lmp2 specific antibody and uses thereof |
| MX388698B (es) * | 2014-09-30 | 2025-03-20 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171). |
| MX2018014950A (es) * | 2016-06-07 | 2019-04-25 | Macrogenics Inc | Terapia de combinacion. |
-
2019
- 2019-02-23 US US16/975,120 patent/US11629184B2/en active Active
- 2019-02-23 WO PCT/US2019/019319 patent/WO2019165326A1/en not_active Ceased
- 2019-02-23 EP EP19756784.5A patent/EP3755327A4/en not_active Withdrawn
- 2019-02-23 JP JP2020544204A patent/JP2021518748A/ja active Pending
- 2019-02-23 CN CN201980027708.7A patent/CN112040949A/zh active Pending